SNAI2 and familial pancreatic carcinoma: (−)-epigallocatechin-3-gallate (EGCG) is a compound without known target, but in cultured pancreatic cancer cells it simultaneously inhibits expression of Hedgehog pathway components, the EMT markers Snail, Slug, and ZEB1, and the pluripotency factors Nanog, c-MYC, and OCT-4 [192].